West Pharma CFO Birkett to retire; Campbell named Chief Proprietary Segment Officer

WEST PHARMACEUTICAL SERVICES INC

CFO Bernard Birkett informed West of intention to retire; search for successor initiated; will remain until transition and then advisory role through Dec 31, 2025.
Shane Campbell appointed SVP, Chief Proprietary Segment Officer effective May 5, 2025; previously at Carlisle Companies and DuPont.
Campbell receives $600K base salary, 75% target bonus (2025 prorated), $1M LTI award (50% PSUs, 25% options, 25% RSUs), $400K sign-on RSU (4-year vest), and $100K sign-on cash bonus.
Birkett joined West in June 2018 and served as CFO, also as CFO & COO from 2022 to April 2024.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Shane Campbell

Senior Vice President, Chief Proprietary Segment Officer

WST · WEST PHARMACEUTICAL SERVICES INC

Effective: 2025-05-05
Filed: April 24, 2025, 7:59 PM ET

On April 24, 2025, the Company announced that it had appointed Shane Campbell to serve as Senior Vice President, Chief Proprietary Segment Officer, effective May 5, 2025

Departed

Bernard Birkett

Senior Vice President & Chief Financial Officer

WST · WEST PHARMACEUTICAL SERVICES INC

Filed: April 24, 2025, 7:59 PM ET

On April 22, 2025, Mr. Bernard Birkett notified West Pharmaceutical Services, Inc. (the “Company”) of his intention to retire as Senior Vice President & Chief Financial Officer later this year.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Shane Campbell was appointed as Senior Vice President, Chief Proprietary Segment Officer at WEST PHARMACEUTICAL SERVICES INC.

Action: appointed
Role: Senior Vice President, Chief Proprietary Segment Officer

Exact text from the filing

On April 24, 2025, the Company announced that it had appointed Shane Campbell to serve as Senior Vice President, Chief Proprietary Segment Officer, effective May 5, 2025

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Bernard Birkett departed as Senior Vice President & Chief Financial Officer at WEST PHARMACEUTICAL SERVICES INC.

Action: intends to retire
Role: Senior Vice President & Chief Financial Officer

Exact text from the filing

On April 22, 2025, Mr. Bernard Birkett notified West Pharmaceutical Services, Inc. (the “Company”) of his intention to retire as Senior Vice President & Chief Financial Officer later this year.

View on SEC.gov

WEST PHARMACEUTICAL SERVICES INC filing history →

Source: SEC EDGAR

accession 0000105770-25-000031

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.